Urothelial signaling

Physiological Reviews

Volumn 93, Issue 2, 2013, Pages 653-680

  Birder, Lori ^a,b   Andersson, Karl Erik ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; AMILORIDE; ANANDAMIDE; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; CAPSAICIN; CATECHOLAMINE; CHONDROITIN SULFATE; CYCLOPHOSPHAMIDE; DOBUTAMINE; HC 067047; HEPARIN; ISOPRENALINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NERVE GROWTH FACTOR ANTIBODY; NICOTINE; NICOTINIC RECEPTOR; ONO 8539; PENTOSAN POLYSULFATE; PF 290761702; PLACEBO; POTASSIUM CHLORIDE; PROTAMINE SULFATE; PURINERGIC P2X3 RECEPTOR; RESINIFERATOXIN; TERBUTALINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BLADDER; BLADDER DISEASE; BLADDER MUCOSA; BLADDER WALL; CELL COMMUNICATION; CELL TYPE; CENTRAL NERVOUS SYSTEM; CYSTALGIA; DETRUSOR MUSCLE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CYSTITIS; KIDNEY PELVIS; LAMINA PROPRIA; LOWER URINARY TRACT SYMPTOM; MECHANICAL STIMULATION; MICTURITION; NERVE CELL EXCITABILITY; NONHUMAN; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STIMULATION; THERMAL STIMULATION; URETER; URINE RETENTION; UROTHELIUM; WATER FLOW;

ANIMALS; HUMANS; MUSCLE, SMOOTH; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; URINARY BLADDER; URINARY BLADDER DISEASES; UROTHELIUM;

EID: 84878491899     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00030.2012     Document Type: Article

References (310)

1. Abraham P, Rabi S, Selvakumar D. Protective effect of aminoguanidine against oxidative stress and bladder injury in cyclophosphamide-induced hemorrhagic cystitis in rat. Cell Biochem Funct 27: 56-62, 2009.
2. Abrams P, Amarenco G, Haab F. Urinary prostaglandin E2 levels are elevated in patients with overactive bladder and painful bladder syndrome and correlate with bladder diary symptoms. EAU Abstr 783: 2010.
3. Acharya P, Beckel J, Ruiz WG, Wang E, Rojas R, Birder L, Apodaca G. Distribution of the tight junction proteins ZO-1, occludin, and claudin-4,-8, and-12 in bladder epithelium. Am J Physiol Renal Physiol 287: F305-F318, 2004.
4. Aitken KJ, Bagli DJ. The bladder extracellular matrix. Part I: architecture, development and disease. Nat Rev Urol 6: 596-611, 2009.
5. Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ. Effects of CL316,243, a beta 3 adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 29: 771-776, 2010.
6. Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesicle acrolein treatment. Eur Urol 59: 264-271, 2011.
7. Aizawa N, Wyndaele JJ, Homma Y, Igawa Y. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Neurourol Urodyn 31: 148-155, 2012.
8. Al-Motabagani MA. Age-related changes in the urinary bladder of the female albino rats. Int J Morphol 23: 309-316, 2005.
9. Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res 57: 2008.
10. Anderson G, Palermo J, Schilling J, Roth R, Heuser J, Hultgren S. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301: 105-107, 2003.
11. Andersson KE. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol 59: 377-386, 2011.
12. Andersson KE. Bladder activation: afferent mechanisms. Urology 59: 43-50, 2002.
13. Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn 29: 97-106, 2010.
14. Andersson KE. Overactive bladder-pharmacological aspects. Scand J Urol Nephrol Suppl 210: 72-81, 2003.
15. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56: 581-631, 2004.
16. Andersson KE, Fullhase C, Soler R. Urothelial effects of oral agents for overactive bladder. Curr Urol Rep 9: 459-464, 2008.
17. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int 106: 1114-1127, 2010.
18. Andersson KE, Persson K. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol 175: 43-53, 1995.
19. Andrade EL, Ferreira J, Andre E, Calixto JB. Contractile mechanisms coupled to TRPA1 receptor activation in rat urinary bladder. Biochem Pharm 72: 104-114, 2006.
20. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 5: 117-128, 2004.
21. Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int 72: 1057-1064, 2007.
22. Apodaca G, Kiss S, Ruiz W, Meyers S, Zeidel M, Birder L. Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol Renal Physiol 284: F966-F976, 2003.
23. Apostolidis A, Brady CM, Yoangou Y, Davis J, Fowler CJ, Anand P. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 65: 400-405, 2005.
24. Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 50: 1299-1305, 2006.
25. Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53: 1245-1253, 2008.
26. Araki I. TRP channels in urinary bladder mechanosensation. Adv Exp Med Biol 704: 861-879, 2011.
27. Araki I, Du S, Kobayashi H, Sawada N, Mochizuki T, Zakoji H, Takeda M. Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol 15: 681-687, 2008.
28. Arrighi N, Bodei S, Lucente A, Michel MC, Zani D, Simeone C, Cunico SC, Spano P, Sigala S. Muscarinic receptors stimulate cell proliferation in the human urotheliumderived cell line UROtsa. Pharmacol Res 64: 420-425, 2011.
29. Arrighi N, Bodei S, Peroni A, Mirabella G, Zani D, Simeone C, Cunico SC, Spano P, Signala S. Detection of muscarinic receptor subtypes in human urinary bladder mucosa: age and gender-dependent modifications. Neurourol Urodyn 27: 421-428, 2008.
30. Artim DE, Bazely F, Daugherty SL, Sculptoreanu A, Koronowski KB, Schopfer FJ, Woodcock SR, Freeman BA, de Groat WC. Nitro-oleic acid targets transient receptor potential (TRP) channels in capsaicin sensitive afferent nerves of rat urinary bladder. Exp Neurol 232: 90-99, 2011.
31. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 36: 657-666, 2000.
32. Balestreire EM, Apodaca G. Apical EGF receptor signaling: regulation of stretchdependent exocytosis in bladder umbrella cells. Mol Biol Cell 13: 830-843, 2007.
33. Bassuk JA, Cockrane K, Mitchell ME. Induction of urothelial cell proliferation by fibroblast growth factor-7 in RAG1-deficient mice. Adv Exp Med Biol 539: 623-633, 2003.
34. Beckel JM, Birder LA. Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat. J Physiol PMID: 22250215: 2012.
35. Beckel JM, Kanai AJ, Lee SJ, de Groat WC, Birder LA. Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol Renal Physiol 290: F103-F110, 2006.
36. Birder LA, Apodaca G, de Groat WC, Kanai AJ. Adrenergic and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol Renal Physiol 275: F226-F229, 1998.
37. Birder LA, Barrick SR, Roppolo JR, Kanai AJ, de Groat WC, Kiss S, Buffington CAT. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 285: F423-F429, 2003.
38. Birder LA, de Groat WC. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract 4: 46-54, 2007.
39. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ, Caterina MJ. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 98: 13396-13401, 2001.
40. Birder LA, Kullmann FA, Lee H, Barrick S, de Groat WC, Kanai A, Caterina M. Activation of urothelial transient receptor potential vanilloid 4 by 4alpha phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat. J Pharm Exp Ther 323: 227-235, 2007.
41. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick SR, Kanai AJ, Wang E, Ruiz WG, de Groat WC, Apodaca G, Watkins S, Caterina MJ. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5: 856-860, 2002.
42. Birder LA, Nealen ML, Kiss S, de Groat WC, Caterina MJ, Wang E, Apodaca G, Kanai AJ. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22: 8063-8070, 2002.
43. Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington Roppolo CA, JR, Ford AP, de Groat WC, Burnstock G. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats witn interstitial cystitis. Am J Physiol Renal Physiol 287: F1084-F1091, 2004.
44. Birder LA, Wolf-Johnston AS, Chib MK. Beyond neurons: involvement of urothelial and glial cells in bladder function. Neurourol Urodyn 29: 88-96, 2010.
45. Birder LA, Wolf-Johnston AS, Sun Y, Chai TC. Alteration in TRPV1 and muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells. Acta Physiol. In press.
46. Birder LA, Wolf-Johnston A, Buffington CAT, Roppolo JR, de Groat WC, Kanai AJ. Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 173: 625-629, 2005.
47. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13: 625-630, 2007.
48. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to estrogen status. BJU Int 86: 32-38, 2000.
49. Brady CM, Apostolidis A, Yiangou Y, Baecker PA, Ford AP, Freeman A, Jacques Fowler TS, Anand P. P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 46: 247-253, 2004.
50. Brunet LJ, Gold GH, Ngai J. General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel. Neuron 17: 681-683, 1996.
51. Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, Lips KS. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80: 2303-2307, 2007.
52. Buffington CA. A watershed year for interstitial cystitis. J Urol 183: 854-855, 2010.
53. Buffington CA. Bladder pain syndrome/interstitial cystitis. In: Urogenital Pain in Clinical Practice, edited by Baranowski AP, Abrams P, and Fall M. New York: Informa Healthcare USA, 2008, p. 169-183.
54. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmcol Sci 22: 182-188, 2001.
55. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194: 335-342, 1999.
56. Burnstock G. Targeting the visceral purinergic system for pain control. Curr Opin Pharmacol 12: 80-86, 2012.
57. Cao DS, Yu SQ, Premkumar LS. Modulation of transient receptor potential vanilloid 4-mediated membrane currents and synaptic transmission by protein kinase C. Mol Pain 10: 50-55, 2009.
58. Carattino MD, Sheng S, Kleyman TR. Mutations in the pore region modify epithelial sodium channel gating by shear stress. J Biol Chem 280: 4393-4401, 2005.
59. Caremel R, Oger-Roussel S, Behr-Roussel D, Grise P, Giuliano FA. Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 2010.
60. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824, 1997.
61. Chai TC, Gray ML, Steer WD. The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neural plasticity. J Urol 160: 34-38, 1998.
62. Chai TC, Keay S. New theories in interstitial cystitis. Nat Clin Pract Urol 1: 85-89, 2004.
63. Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162: 3-11, 1999.
64. Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki R. Drug insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Prac Urol 5: 319-328, 2008.
65. Chapple C, Abrams P, Andersson KE. A randomised, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of the EP-1 receptor antagonist, ONO-8539, in overactive bladder syndrome. AUA Abstr 2011.
66. Charrua A, Boudes M, de Ridder D, Cruz CD, Cruz F. TRPV1 and TRPV4 expression in bladder neurons during normal condition and during cystitis. Eur Urol. In press.
67. Charrua A, Cruz CD, Cruz F, Avelino A. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177: 1537-1541, 2007.
68. Charrua A, Cruz CD, Narayanan S. CRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. J Urol 181: 379-386, 2009.
69. Charrua A, Reguenga C, Cordeiro JM. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells. J Urol 182: 2944-2950, 2009a.
70. Cheng J, Huang H, Zhang ZT. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumore growth. Cancer Res 62: 4157-4163, 2002.
71. Cheng S, Scigalla FP, Speroni di Fenizio P, Zhang ZG, Stolzenberg JY, Neuhaus J. ATP enhances spontaneous calcium activity in cultured suburothelial myofibroblasts of the human bladder. PLoS One 6: e2569, 2011.
72. Chess-Williams R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autocoid Pharmacol 22: 133-145, 2002.
73. Chiang G, Patra P, Letourneau E. Pentosanpolysulfate (Elmiron) is a potent inhibitor of mast cell histamine secretion. Adv Exp Med Biol 539: 713-739, 2003.
74. Chiang G, Patra P, Letourneau R. Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol 164: 2119-2125, 2000.
75. Chopra B, Barrick SR, Meyers S, Beckel JM, Zeidel ML, Ford AP, de Groat WC, Birder LA. Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 562: 859-871, 2005.
76. Chopra B, Gever J, Barrick SR, Hanna-Mitchell AT, Beckel JM, Ford AP, Birder LA. Expression and function of rat urothelial P2Y receptors. Am J Physiol Renal Physiol 294: F821-F829, 2008.
77. Cockayne DA, Dunn PM, Zhong Y, Rong W, Hamilton SG, Knight GE, Ruan HZ, Ma B, Yip P, Nunn P, McMahon SB, Burnstock G, Ford AP. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X3 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567: 621-639, 2005.
78. Cockayne DA, Hamilton SG, Zhu Q, M, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, BurnstockG, McMahon SB, Ford AP. Urinary bladder hypotreflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407: 1011-1015, 2000.
79. Combrisson H, Allix S, Robain G. Influence of temperature on urethra to bladder micturition reflex in the awake ewe. Neurourol Urodyn 26: 290-295, 2007.
80. Conrads TP, Tocci GM, Hood BL, Zhang CO, Guo L, Koch KR, Michejda CJ, Veenstra TD, Keay SK. CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem 281: 37836-37843, 2006.
81. Cruz C, Cruz F. Spinal cord injury and bladder dysfunction: new ideas about an old problem. Scientific World J 11: 214-234, 2011.
82. Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourol Urodyn 26: 920-927, 2007.
83. Daly D, Rong W, Chess-Williams R, Chapple C, Grundy D. Bladder afferent activity in wild-type and TRPV1 knockout mice. J Physiol 583: 663-674, 2007.
84. De Groat WC, Kruse MN, Vizzard MA, Cheng CL, Araki I, Yoshimura N. Modification of urinary bladder function after spinal cord injury. Adv Neurol 72: 347-364, 1997.
85. De Laet K, de Wachter S, Wyndaele JJ. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics. Neurourol Urodyn 25: 156-161, 2006.
86. De Wachter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 169:1892-1895, 2003.
87. Dimitrakov J, Kroenke K, Steers WD. Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med 167: 1922-1929, 2007.
88. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 136: 265-271, 1983.
89. Dmitrieva N, McMahon SB. Sensitization of visceral afferents by nerve growth factor in the adult rat. Pain 66: 87-97, 1996.
90. Drake MJ, Fry CH, Eyden B. Structural characterization of myofibroblasts in the bladder. BJU Int 97: 29-32, 2006.
91. Du S, Araki I, Mikami Y, Zakoji H, Beppu M, Yoshiyama M, Takeda M. Amiloridesensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology 69: 590-595, 2007.
92. El-Badawi A, Schenk EA. Dual innervation of the mammalian urinary bladder. A histochemical study of the distribution of cholinergic and adrenergic nerves. Am J Anat 119: 405-428, 1966.
93. Elneil S, Skepper JN, Kidd EJ, Williamson JG, Ferguson DR. Distribution of PX2(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology 63: 120-128, 2001.
94. Erickson DR, Tomaszewski JE, Kunselman AR. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 179: 1850-1856, 2008.
95. Evans RJ, Moldwin RM, Cossons N, Darekar A, Mills IW, Scholfield D. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J Urol 185: 1716-1721, 2011.
96. Everaerts W, Gevaert T, Nilius B, de Ridder D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn 27: 264-273, 2008.
97. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, Hayward NJ, McNamara CR, Xue F, Moran MM, Strassmaier T, Uykal E, Owslanik G, Vennekens R, de Ridder D, Nilius B, Fanger CM, Voets T. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci USA 107: 19084-19089, 2010.
98. Eyden B. Are there myofibroblasts in normal bladder? Eur Urol 56: 427-429, 2009.
99. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rat urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol 505: 503-511, 1997.
100. Folkerts G, Nijkamp FP. Airway epithelium: more than just a barrier. Trends Pharmcol Sci 19: 334-241, 1998.
101. Ford AP. In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signalling 8: S3-S26, 2012.
102. Ford AP, Cockayne DA. ATP and P2X purinoceptors in urinary tract disorders. Handb Exp Pharmacol 202: 485-526, 2011.
103. Fovaeus M, Fujiwara M, Hogestatt ED, Persson K, Andersson KE. A non-nitergic smooth muscle relaxant factor released from rat urinary bladder by muscarinic receptor stimulation. J Urol 161: 649-653, 1999.
104. Fraser MO, Chuang YC, Tyagi P, Yokoyama T, Yoshimura N, Huang L, de Groat WC, Chancellor MB. Intravesical liposome administration: a novel treatment for hyperactive bladder in the rat. Urology 61: 656-663, 2003.
105. Frias B, Charrua A, Avelino A, Michel MC, Cruz F, Cruz CD. Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input. BJU Int 110: E422-429, 2012.
106. Fry CH, Sui GP, Kanai AJ, Wu C. The function of suburothelial myofibroblasts in the bladder. Neurourol Urodyn 26: 914-919, 2007.
107. Fry CH, Young JS, Jabr RI, McCarthy C, Ikeda Y, Kanai AJ. Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists. Am J Physiol Renal Physiol 302: F1447-F1454, 2012.
108. Gabella G, Davis C. Distribution of afferent axons in the bladder of rats. J Neurocytol 27: 141-155, 1998.
109. Georgopoulos NT, Kirkwood LA, Walder DC, Southgate J. Differential regulation of growth-promoting signalling pathways by E-cadherin. PLoS One 5: e13621, 2010.
110. Gevaert T, De Vos R, Everaerts W, Libbrecht L, Van Der Aa F, van den Oord J, Roskams T, De Ridder D. Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome. J Cell Mol Med 15: 2586-2593, 2011b.
111. Gevaert T, de Vos R, van der Aa F, Joniau S, van den Oord J, Roskams T, de Ridder D. Identification of telocytes in the upper lamina propria of the human urinary tract. J Cell Mol Med 2011.
112. Gevaert T, Vriens J, Segal A, Evaraerts W, Roskams T, Talavera K, Owsianik G, Liedtke W, Daelemans D, De Wachter I, Van Leuven F, Voets T, De Ridder D, Nilius B. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462, 2007.
113. Gever JR, Soto R, Henningsen RA, Martin RS, Hackos DH, Panicker S, Rubas W, Oglesby IB, Dillon MP, Milla ME, Burnstock G, Ford AP. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol 160: 1387098, 2010.
114. Giannantoni A, Amantini C, Proietti S, Farfariello V, Vianello A, Santoni G, Porena M. Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors. EAU Abstr 2012.
115. Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 175: 2341-2344, 2006.
116. Gillespie JI, Marerink-van Ittersum M, de Vente J. Expression of neuronal nitric oxide synthase (nNOS) and nitric-oxide-induced changes in cGMP in the urothelial layer of the guinea pig bladder. Cell Tissue Res 321: 341-351, 2005.
117. Gillespie JI, Markerink-van Ittersum M, de Vente J. Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells. Cell Tissue Res 325: 325-332, 2006.
118. Gillespie JI, Markerink-van Ittersum M, de Vente J. Sensory collaterals, intramural ganglia and motor nerves in the guinea-pig bladder: evidence for intramural neural circuits. Cell Tissue Res 325: 33-45, 2006.
119. Girard BM, Malley SE, Vizzard MA. Neurotrophin/receptor expression in urinary bladder of mice with overexpression of NGF in urothelium. Am J Physiol Renal Physiol 300: F345-F355, 2011.
120. Gosling JA, Dixon JS. Sensory nerves in the mammalian urinary tract. An evaluation using light and electron microscopy. J Anat 117: 133-144, 1974.
121. Graham E, Chai TC. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 7: 440-446, 2006.
122. Grasso EJ, Scalambro MB, Calderon RO. Differential response of the urothelial V-ATPase activity to the lipid environment. Cell Biochem Biophys 61: 157-168, 2011.
123. Grol S, Essers PB, van Koeveringe GA, Martinez-Martinez P, de Vente J, Gillespie JI. M(3) muscarinic receptor expression on suburothelial interstitial cells. BJU Int 104: 398-405, 2009.
124. Gupta GN, Lu SG, Gold MS, Chai TC. Bladder urothelial cells from patients with interstitial cystitis have an increased sensitivity to carbachol. Neurourol Urodyn 28: 1022-1027, 2009.
125. Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, DeGroat WC, Birder LA. Non-neuronal acetylcholine and urinary blader urothelium. Life Sci 80: 2298-2302, 2007.
126. Hashimoto Y, Ushiki T, Uchida T, Yamada J, Iwanaga T. Scanning electron microscopic observation of apical sites of open-type paraneurons in the stomach, intestine and urethra. Arch Histol Cytol 62: 181-189, 1999.
127. Hashitani H, Takano H, Fujita K, Mitsui R, Suzuki H. Functional properties of suburothelial microvessels in the rat bladder. J Urol 185: 2382-2391, 2011.
128. Hawthorn MH, Chapple CR, Cock M, Chess-Williams R. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 129: 416-419, 2000.
129. Heppner TJ, Layne JJ, Pearson JM, Sarkissian H, Nelson MT. Unique properties of muscularis mucosae smooth muscle in guinea pig urinary bladder. Am J Physiol Regul Integr Comp Physiol 301: R351-R362, 2011.
130. Hicks GA. TRP channels as therapeutic targets: hot property, or time to cool down? Neurogastroenterol Motil 18: 590-594, 2006.
131. Hicks M. The mammalian urinary bladder: an accomodating organ. Biol Rev 50: 215-246, 1975.
132. Hicks M, Ketterer B, Warren R. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Phil Trans R Soc Lond 268: 23-38, 1974.
133. Ho DR, Chen CS, Lin WY, Chang PJ, Huang YC. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis. Int J Urol 18: 525-531, 2011.
134. Hosseini A, Ehren I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol 172: 2261-2265, 2004.
135. Hurst RE. Structure, function and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12: 3-10, 1994.
136. Hurst RE, Moldwin RM, Mulhulland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology 69: 17-23, 2007.
137. Igawa Y, Aizawa N, Homma Y. Beta 3 adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol 51: 811-818, 2010.
138. Iggo A. Tension receptors in the stomach and the urinary bladder. J Physiol 128: 593-607, 1955.
139. Iijima K, de Wachter S, Wyndaele JJ. Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve. Eur Urol 52: 842-847, 2007.
140. Ikeda Y, Birder L, Buffington C, Roppolo J, Kanai A. Mucosal muscarinic receptors enhance bladder activity in cats with feline interstitial cystitis. J Urol 181: 1415-1422, 2009.
141. Ikeda Y, Fry C, Hayashi F, Stolz D, Griffiths D, Kanai A. Role of gap junctions in spontaneous activity of the rat bladder. Am J Physiol Renal Physiol 293: F1018-F1025, 2007.
142. Ikeda Y, Kanai A. Urotheliogenic modulation of intrinsic activity in spinal cord-transected rat bladders: role of mucosal muscarinic receptors. Am J Physiol Renal Physiol 295: F454-F461, 2008.
143. Imamov O, Yakimchuk K, Morani A. Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis. Proc Natl Acad Sci USA 104: 9806-9809, 2007.
144. Ishihama H, Momota Y, Yanase H, Wang X, de Groat WC, Kawatani M. Activation of alpha 1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 175: 358-364, 2006.
145. Iwatsuki K, Ichikawa R, Hiasa M, Moriyama Y, Torii K, Uneyama H. Identification of the vesicular nucleotide transporter (VNUT) in taste cells. Biochem Biophy Res Commun 388: 1-5, 2009.
146. Janssen DA, Hoenderop JG, Jansen KC. The mechanoreceptor TRPV4 is localized in adherence junctions of the human bladder urothelium: a morphological study. J Urol 186: 1121-1127, 2011.
147. Jen PY, Dixon JS, Gosling JA. Immunohistochemical localization of neuromarkers and neuropeptides in human fetal and neonatal urinary bladder. Br J Urol 75: 230-235, 1995.
148. Ji RR, Samad TA, Jin SX. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 26: 57-68, 2002.
149. Johnston L, Woolsey S, Cunningham RM, O'Kane H, Duggan B, Keane P, McCloskey KD. Morphological expression of KIT positive interstitial cells of Cajal in human bladder. J Urol 184: 370-377, 2010.
150. Kaan TK, Yip PK, Grist J, Cefalu JS, Nunn PA, Ford AP, Zhong Y, McMahon SB. Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord. J Neurosci 30: 4503-4507, 2010a.
151. Kaan TK, Yip PK, Patel S, Davies M, Marchand F, Cockayne DA, Nunn PA, Dickenson AH, Ford AP, Zhong Y, Malcangio M, McMahon SB. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133: 2549-2564, 2010.
152. Kalota SJ, Stain PC, Parsons CL. Prevention of acrolein-induced bladder injury by pentosanpolysulfate. J Urol 148: 163-166, 1992.
153. Kanai AJ, Andersson KE. Bladder afferent signaling: recent findings. J Urol 183: 1288-1295, 2010.
154. Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, de Wachter S. Researching bladder afferents determining the effects of β (3)-adrenergic receptor agonists and botulinum toxin type A. Neurol Urodyn 30: 684-691, 2011.
155. Kaufman J, Tyagi P, Chancellor MB. Intravesical liposomal (LP09) instillation protects bladder urothelium from chemical irritation. Am Urol Assoc 1506: 2009.
156. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Zhang CO, Koch KR, Michejda CJ. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 101: 11803-11808, 2004.
157. Keay SK, Zhang CO, Shoenfelt J. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57: 9-14, 2001.
158. Kennelly MJ, Arena KC, Shaffer N, Bennett ME, Grill WM, Grill JH, Boggs JW. Electrical stimulation of the urethra evokes bladder contractions in a woman with spinal cord injury. J Spinal Cord Med 33: 261-265, 2010.
159. Khanderwal P, Abraham SN, Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol 297: F1477-F1501, 2009.
160. Kim JC, Park EY, Hong SH. Changes of urinary nerve growth factor and prostaglandins in male subjects with overactive bladder symptom. Int J Urol 12: 875-880, 2005.
161. Knight GE, Bodin P, de Groat WC, Burnstock G. ATP is released from guinea pig ureter epithelium on distension. Am J Physiol Renal Physiol 282: F281-F288, 2002.
162. Koh BH, Roy R, Hollywood MA, Thornbury KD, McHale NG, Sergeant GP, Hatton WF, Ward SM, Sanders KM, Koh SD. PDGFRalpha cells in mouse urinary bladder: a new class of interstitial cells. J Cell Mol Med 16: 691-700, 2012.
163. Korkmaz A, Oter S, Sadir S, Coskun O, Topal T, Ozler M, Bilgic H. Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol 173: 1793-1796, 2005.
164. Kreft ME, Jezernik K, Kreft M, Romih R. Apical plasma membrane traffic in superficial cells of bladder urothelium. Ann NY Acad Sci 1152: 18-29, 2009.
165. Kreft ME, Romih R, Kreft M, Jezernik K. Endocytotic activity of bladder superficial urothelial cells is inversely related to their differentiation stage. Differentiation 77: 48-59, 2009.
166. Kullmann FA, Downs TR, Artim DE, Limberg BJ, Shah M, Contract D, de Groat WC, Rosenbaum JS. Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol Urodyn 30: 144-150, 2011.
167. Kullmann FA, Limberg BJ, Artim DE, Shah M, Downs TR, Contract D, Wos J, Rosenbaum JS, de Groat WC. Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy. J Pharmacol Exp Ther 330: 704-717, 2009.
168. Kullmann FA, Shah MA, Birder LA, de Groat WC. Functional TRP and ASIC-like channels in cultured urothelial cells from the rat. Am J Physiol Renal Physiol 296: F892-F901, 2009.
169. Kumar V, Chapple CR, Rosario D, Tophill PR, Chess-Williams R. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic. Eur Urol 57: 1087-1092, 2010.
170. Kummer W, Wiegand S, Akinci S, Schinkel AH, Wess J, Koepsell H, Habergerger RV, Lips KS. Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse. J Mol Neurosci 30: 67-68, 2006.
171. Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for overactive bladder. Rev Urol 12: e69-e77, 2010.
172. Kurizaki Y, Ishizuka O, Imamura T, Midori I, Ogawa T, Igawa Y, Nishizawa O, Andersson KE. Relation between expression of alpha-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol Suppl. In press.
173. Kurizaki Y, Ishizuka O, Imamura T, Nishizawa O, Andersson KE. Expression of betaadrenoceptor mRNA in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Neurourol Urodyn. In press.
174. LaBerge J, Malley SE, Zvarova K, Vizzard MA. Expression of corticotrophin-releasing factor and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol 291: R692-R703, 2006.
175. Lavelle J, Meyers S, Ramage R, Bastacky S, Doty D, Apodaca G, Zeidel ML. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol 283: F242-F253, 2002.
176. Lavelle JP, Meyers SA, Ruiz WG, Buffington CAT, Zeidel M, Apodaca G. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol 278: F540-F553, 2000.
177. Lee HY, Bardini M, Burnstock G. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol 163: 2002-2007, 2000.
178. Lee JH, Kim JW, Im YS, Seong GJ, Lee HK. Cyclosporine A induces nerve growth factor expression via activation of MAPK p38 and NFAT5. Cornea 1: 19-24, 2011.
179. Lee T, Hedlund P, Newgreen D. Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol 177: 1562-1567, 2007.
180. Li J, Karaplis AC, Huang DC, Siegel PM, Camirand A, Yang XF, Muller WJ, Kremer R. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest 121: 4655-4669, 2011.
181. Li M, Sun Y, Simard JM, Chai TC. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol Urodyn 30: 606-611, 2011.
182. Liang FX, Bosland MC, Huang H, Romih R, Baptiste S, Deng FM, Wu XR, Shapiro E, Sun TT. Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol 171: 835-844, 2005.
183. Liang FX, Riedel I, Deng FM, Zhou G, Wu C, Wu WR, Kong WP, Moll R, Sun TT. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. J Biochem 355: 13-18, 2001.
184. Liedtke W. TRPV4 plays an evolutionary conserved role in the transduction of osmotic and mechanical stimuli in live animals. Pflügers Arch 451: 176-180, 2005.
185. Limberg BJ, Andersson KE, Kullmann AF, Burner G, de Groat WC, Rosenbaum JS. Beta-adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res 342: 295-306, 2010.
186. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog Br Res 109: 125-137, 1996.
187. Lips KS, Wunsch J, Zarghooni S, Bschleipfer T, Schukowski K, Weidner W, Wessler I, Schwantes U, Koepsell H, Kummer W. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol 51: 1042-1053, 2007.
188. Liu F, Takahashi N, Yamaguchi O. Expression of P2X3 purinoceptors in suburothelial myofibroblasts of the normal human urinary bladder. Int J Urol 16: 570-575, 2009.
189. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56: 700-707, 2009.
190. Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70: 463-468, 2007.
191. Liu HT, Kuo HC. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity. BJU Int 100: 1086-1090, 2007.
192. Liu HT, Wang YS, Chancellor M. Nerve growth factor levels in urine correlate with expression in urothelium but not suburothelium in the bladder tissues of overactive bladder syndrome. J Urol 183: e644-645, 2010.
193. Liu L, Manseifld KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E. The molecular basis or urgency: regional difference of vanilloid receptor expression in the human bladder. Neurourol Urodyn 26: 433-438, 2007.
194. Lowe EM, Anand P, Terenghi G. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79: 572-577, 1997.
195. Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 101: 366-370, 2008.
196. Lumpkin EA, Caterina MJ. Mechanisms of sensory transduction in the skin. Nature 445: 858-865, 2007.
197. MacDiarmid SA, Sand PL. Diagnosis of interstitial cystitis/painful bladder syndrome in patients with overactive bladder symptoms. Rev Urol 184: 9-16, 2007.
198. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, Turini D. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 142: 150-154, 1989.
199. Mahmoud HM, Refaat SH, Abdel-Aal IH, Saudy FZ. Age-Related Changes in the urinary bladder of female Albino Rats. Egypt J Histol 27: 402-416, 2004.
200. Mamalaki A, Tzartos SJ. Nicotinic acetylcholine receptor: structure, function and main immunogenic region. Adv Neurol 4: 339-354, 1994.
201. Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in aging. Br J Pharmacol 144: 1089-1099, 2005.
202. Martin BF. Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. J Anat 112: 433-455, 1972.
203. Martinez-Bianchi V, Halstater BH. Urologic chronic pelvic pain syndrome. Prim Care 37: 527-546, 2010.
204. Masunaga K, Chapple CR, McKay NG, Yoshida M, Sellers DJ. The beta 3-adrenoceptor mediates the inhibitory effects of beta-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 29: 2010.
205. May A. Chronic pain may change the structure of the brain. Pain 137: 7-15, 2008.
206. Mayer EA, Bushnell MC. Functional pain disorders: time for a paradigm shift? In: Functional Pain Syndromes: Presentation and Pathophysiology, edited by EA and Mayer Bushnell MC. Seattle, WA: IASP Press, 2009, p. 19-33.
207. McCloskey KD. Interstitial cells in the urinary bladder-localization and function. Neurourol Urodyn 29: 82-87, 2010.
208. McCloskey KD. Interstitial cells of Cajal in the urinary tract. Handb Exp Pharmacol 202: 233-254, 2011.
209. Micera A, Lambiase A, Stampachiacchiere B. Nerve growth factor and tissue repair remodeling: trkA (NGFR) and p75 (NTR), two receptors one fate. Cytokine Growth Factor Rev 18: 245-246, 2007.
210. Monaghan KP, Johnston LL, McCloskey KD. Identification of PDGFRalpha-positive populations of interstitial cells in human and guinea-pig bladder. J Urol 188: 639-647, 2012.
211. Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156: 45-48, 1996.
212. Moro C, Uchiyama J, Chess-Williams R. Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. Urology 78: 1442-1449, 2011.
213. Morrison JFB. Sensations arising from the lower urinary tract. In: The Physiology of the Lower Urinary Tract, edited by Torrens M, Morrison JFB. Berlin: Springer-Verlag, 1987, p. 89-131.
214. Mukerji G, Yiangou Y, Grogono J, Underwood J, Agarwal SK, Khullar V, Anand P. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176: 367-373, 2006.
215. Munoz A, Gangitano DA, Smith CP, Boone TB, Somogyi GT. Removal of urothelium affects bladder contractility and release of ATP but not release of NO in rat urinary bladder. BMC Urol 24: 10, 2010.
216. Murakami S, Chapple CR, Akino H, Sellers DJ, Chess-Williams R. The role of the urothelium in mediating bladder responses to isoprenaline. BJU Int 99: 669-673, 2007.
217. Namasivayam S, Eardley I, Morrison JF. Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. BJU Int 84: 854-860, 1999.
218. Neuhaus J, Pfeiffer F, Wolburg H, Horn LC, Dorschner W. Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int 96: 854-860, 1999.
219. Nickel JC, Egerdie RB, Steinhoff G, Palmer B, Hanno P. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/ painful bladder syndrome. Urology 76: 804-809, 2010.
220. Nickel JC, Hanno P, Kumar K, Thomas H. Second multicenter, randomized, doubleblind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Urology 79: 1220-1225, 2012.
221. Nile CJ, de Vente J, Gillespie JI. Stretch independent regulation of prostaglandin E2 production within the isolated guinea-pig lamina propria. BJU Int 105: 540-548, 2010.
222. Nile CJ, Gillespie JI. Interactions between cholinergic and prostaglandin signaling elements in the urothelium: role for muscarinic type 2 receptors. Urology 79: 217-223, 2012.
223. Nirmal J, Tyagi P, Dang L, Hanna-Mitchell A, Wolf-Johnston A, Kaufman J, Birder L, Chancellor M. Endocytosis uptake of liposomes in urothelium cells detected by transmission electron microscopy. Am Urol Assoc 1202359: 2012.
224. Ochodnicky P, Cruz CD, Yoshimura N, Michel MC. Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn 30: 1227-1241, 2011.
225. Olsen SM, Stover JD, Nagatomi J. Examining the role of mechanosensitive ion channels in pressure mechanotransduction in rat bladder urothelial cells. Ann Biomed Eng 39: 688-697, 2011.
226. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621, 2004.
227. Otsuka A, Shinbo H, Matsumoto R, Kurita Y, Ozono S. Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn-Schmiedebergs Arch Pharmcol 377: 473-481, 2008.
228. Ozawa H, Chancellor MB, Jung SY, Yokoyama T, Fraser MO, Yu Y, de Groat WC, Yoshimura N. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 162: 2211-2216, 1999.
229. Pandita RK, Andersson KE. Intravesical adenosine triphophate stimulates the micturition reflex in awake, freely moving rats. J Urol 168: 1230-1234, 2002.
230. Pandita RK, Mizusawa H, Andersson KE. Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats. J Urol 164: 545-550, 2000.
231. Paner GP, Ro JY, Wojeik EM, Venkataraman G, Datta MW, Amin MB. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 31: 1420-1429, 2007.
232. Paner GP, Shen SS, Lapentino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic stages of invasive urothelial carcinoma. Am J Surg Pathol 33: 91-98, 2009.
233. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143: 139-142, 1990.
234. Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69: 9-16, 2007.
235. Parsons CL. The therapeutic role of sulfated polysaccharides in the urinary bladder. Urol Clin North Am 21: 93-100, 1994.
236. Parsons CL, Forrest J, Nickel JC. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 59: 329-333, 2002.
237. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145: 732-735, 1991.
238. Persson K, Alm P, Johansson K, Larsson B, Andersson KE. Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects. Br J Pharmacol 110: 521-530, 1993.
239. Persson K, Igawa Y, Mattiasson A, Andersson KE. Effects of inhibition of the L-arginine/ nitric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br J Pharmacol 107: 178-184, 1992.
240. Peters KM, Hasenau DL, Anthony M, Kaufman J, Killinger KA, Chancellor MB. Novel therapy with intravesical liposomes for ulcerative interstitial cystitis/painful bladder syndrome. LUTS. In press.
241. Planells-Cases R, Valente P, Ferrer-Montiel A, Qin F, Szallasi A. Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. Adv Exp Med Biol 704: 491-515, 2011.
242. Rahnam'i MS, van Koeveringe GA, Essers PB. Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria. J Urol 183: 1241-1247, 2010.
243. Reis H, Tschirdewahn S, Szarvas T, Rubben H, Schmid KW, Grabellus F. Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder. Oncol Lett 2: 1149-1153, 2011.
244. Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn 30: 754-757, 2011.
245. Rofeim O, Hom D, Freid RM. Use of the neodymium:YAG laser for interstitial cystitis: a prospective study. J Urol 166: 134-136, 2001.
246. Romih R, Korosec P, de Mello W, Jezernik K. Differentiation of epithelial cells in the urinary tract. Cell Tissue Res 320: 259-268, 2005.
247. Rong W, Spyer KM, Burnstock G. Activation and sensitization of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol 541: 591-200, 2002.
248. Roosen A, Chapple CR, Dmochowski Fowler RR, CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol 56: 810-819, 2009.
249. Rostand KS, Esko JD. Microbial adherence to and invasion through proteoglycans. Infect Immun 65: 1-8, 1997.
250. Rudick CN, Billips BK, Pavlov VI, Yaggie RE, Schaeffer AJ, Klumpp DJ. Host-pathogen interactions mediating pain of urinary tract infection. J Infect Dis 201: 1240-1249, 2010.
251. Sadhukhan PC, Tchetgen MB, Rackley RR, Vasavada SP, Liou L, Bandyopadhyay SK. Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. J Urol 168: 289-292, 2002.
252. Sanchez-Freire V, Blanchard MG, Burkhard FC, Kessler TM, Kellenberger S, Monastyrskaya K. Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome. J Urol 186: 1509-1516, 2011.
253. Schilling J, Hultgren S. Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli. Int J Antimicrob Agents 19: 457-560, 2002.
254. Schnegelsberg B, Sun TT, Cain G, Bhattacharya A, Nunn PA, Ford AP, Vizzard MA, Cockayne DA. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol 298: R534-R547, 2010.
255. Schroder A, Newgreen D, Andersson KE. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and EP1 receptor knockout mice. J Urol 172: 1166-1170, 2004.
256. Schussler B. Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. Urol Res 18: 349-352, 1990.
257. Shin K, Lee J, Guo N, Kim J, Lim A, Qu L, Mysorekar IU, Beachy PA. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472: 110-116, 2011.
258. Silva C, Ribeiro MJ, Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168: 575-579, 2002.
259. Smet PJ, Moore KH, Jonavicius J. Distribution and colocalization of calcitonin generelated peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77: 37-49, 1997.
260. Smith AL, Leung J, Kun S, Zhang R, Karagiannides I, Raz S, Lee U, Glovatschka V, Pothoulakis C, Bradesi S, Mayer EA, Rodriguez LV. The effects of acute and chronic psychological stress on bladder function in a rodent model. Urology 78: 961-967, 2011.
261. Smith CP, Gangitano DA, Munoz A, Salas NA, Boone TB, Aoki KR, Francis J, Somogyi GT. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury. Neurochem Int 52: 1068-1075, 2008.
262. Snellings AE, Yoo PB, Grill WM. Urethral flow-responsive afferents in the cat sacral dorsal root ganglia. Neurosci Lett 516: 34-38, 2012.
263. Sonar SS, Schwinge D, Kilic A, Yildirim AO, Conrad ML, Seidler K, Muller B, Renz H, Nockher WA. Nerve growth factor enhances Clara cell proliferation after lung injury. Eur Respir J 36: 105-115, 2010.
264. Steers WD, Tuttle JB. Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 3: 101-110, 2006.
265. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinostide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 128: 509-522, 2006.
266. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, Andersson KE, Hogestatt ED, Zygmunt PM. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53: 391-399, 2008.
267. Sui GP, Wu C, Fry CH. Characterization of the purinergic receptor subtype on guinea-pig suburothelial myofibroblasts. BJU Int 97: 1327-1331, 2006.
268. Sui GP, WuC, Fry CH. Electrical characteristics of suburothelial cells isolated from the human bladder. J Urol 171: 938-943, 2004.
269. Sun TT. Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing. Am J Physiol Renal Physiol 291: F9-F21, 2006.
270. Sun Y, Chai TC. Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 290: C27-C34, 2006.
271. Sun Y, Chai TC. Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int 90: 381-385, 2002.
272. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212, 1999.
273. 3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat. J Pharmacol Exp Ther 267: 728-733, 1993.
274. Templeman L, Chapple CR, Chess-Williams R. Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol 167: 742-745, 2002.
275. Teng J, Wang Y, Bjorling DE. Estrogen-induced proliferation of urothelial cells is modulated by nerve growth factor. Am J Physiol Renal Physiol 282: F1075-F1083, 2002.
276. Teng J, Wang ZY, Jarrard DF, Bjorling DE. Roles of estrogen receptor α and β in modulating urothelial cell proliferation. Endocr Relat Cancer 15: 351-364, 2008.
277. Teng J, Wang ZY, Prossnitz ER, Bjorling DE. The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology 149: 4024-4034, 2008.
278. Thomas JC, DeMarco RT, Pope JC. Molecular biology of ureteral bud and trigonal development. Curr Urol Rep 6: 146-151, 2005.
279. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, Sun TT, Schaeffer AJ, Klumpp DJ. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLOS Pathogens 5: 1-17, 2009.
280. Tincello DG, Taylor AH, Spurling SM, Bell SC. Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract. J Urol 181: 1474-1478, 2009.
281. Truschel ST, Ruiz WG, Shulman T, Pilewski J, Sun TT, Zeidel ML, Apodaca G. Primary uroepithelial cultures. A model system to analyze umbrella cell barrier function. J Biol Chem 274: 15020-15029, 1999.
282. Twiss C, Kilpatrick L, Craske M, Buffington CAT, Ornitz E, Rodriguez LV, Mayer EA, Naliboff BD. Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J Urol 181: 2127-2133, 2009.
283. Tyagi P, Chancellor M, Yoshimura N, Huang L. Activity of different phospholipids in attenuating hyperactivity in bladder irritation. BJU Int 101: 627-632, 2008.
284. Tyagi P, Chuang YC, Yoshimura N, Kaufmann J, Chancellor MB. Bladder instillation of liposomes for bladder coating and drug delivery platform. LUTS 1: S90-S93, 2009.
285. Tyagi P, Hsieh VC, Yoshimura N, Kaufman J, Chancellor MB. Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity. BJU Int 104: 1689-1692, 2009.
286. Tyagi P, Thomas CA, Yoshimura N, Chancellor MB. Investigations into the presence of functional beta1, beta2 and beta3-adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol 35: 76-83, 2009.
287. Tyagi S, Tyagi P, Han-le S, Yoshimura N, Chancellor MB, de Miguel F. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol 176: 1673-1678, 2006.
288. Vaidyanathan S, Mansour P, Soni BM, Singh G, Sett P. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder: a hypothesis. BMC Urol 30: 2-5, 2002.
289. Vaidyanathan S, McDicken IW, Ikin AJ, Mansour P, Soni BM, Singh G, Sett P. A study of cytokeratin 20 immunostaining in the urothelium of neuropathic bladder of patients with spinal cord injury. BMC Urol 29: 2-7, 2002.
290. Vaidyanathan S, McDicken IW, Mansour P, Singh G, Soni BM, McCreavy DT, Wiodarski B, Carron JA, Frasser WD, Sett P, Gallagher JA. Parathyroid hormone-related protein (1-34) and urothelial redifferentiation in the neuropathic urinary bladder. Spinal Cord 38: 546-551, 2000.
291. Varley CL, Stahlschmidt J, Lee WC, Holder J, Diggle C, Selby PJ, Trejdosiewicz LK, Southgate J. Role of PPAR gamma and EGFR signaling in the urothelial terminal differentiation process. J Cell Sci 117: 2029-2036, 2004.
292. Varley CL, tahlschmidt J, Smith B, Stower M, Southgate J. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Am J Pathol 164: 1789-1798, 2004.
293. Velasco C, Guarneri L, Leonardi A, Testa R. Effects of intravenous and intravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction. BJU Int 92: 131-136, 2003.
294. Vlaskovska M, Kasakov L, Rong W, Bodin P, Bardini M, Cockayne DA, Ford AP, Burnstock G. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21: 5670-5677, 2001.
295. Walden PD, Durkin MM, Lepor H, Wetzel JM, Gluchowski C, Gustafson EL. Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate. J Urol 157: 1032-1038, 1997.
296. Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115: 2412-2422, 2005.
297. Wang ZY, Wang P, Merriam FV, Bjorling DE. Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice. Pain 139: 158-167, 2008.
298. Westropp JL, Buffington CA. In vivo models of interstitial cystitis. J Urol 167: 694-702, 2002.
299. Westropp JL, Kass PH, Buffington CA. Evaluation of the effects of stress in cats with idiopathic cystitis. Am J Vet Res 67: 731-736, 2006.
300. Wiseman OJ, Fowler CJ, Landon DN. The role of the human bladder lamina propria myofibroblast. BJU Int 91: 89-93, 2003.
301. Wood MW, Breitschwerdt EB, Nordone SK, Linder KE, Gookin JL. Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release. J Comp Pathol 5: 1-9, 2011.
302. Wood SK, Baez MA, Bhatnagar S, Valentino RJ. Social stress-induced bladder dysfunction: potential role of coricotrophin-releasing factor. Am J Physiol Regul Integr Comp Physiol 296: R1671-R1678, 2009.
303. Yamada T, Ugawa S, Ueda T, Ishida Y, Kajita K, Shimada S. Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder. J Histochem Cytochem 57: 277-287, 2009.
304. Yamaguchi O, Chapple CR. Beta3 adrenoceptors in urinary bladder. Neurourol Urodyn 26: 752-756, 2007.
305. Yanase H, Wang X, Momota Y, Nimura T, Kawatani M. The involvement of urothelial alpha1A adrenergic receptor in controlling the micturition reflex. Biomed Res 29: 239-244, 2008.
306. Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, Anand P. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 87: 774-789, 2001.
307. Yu W, Robson SC, Hill WG. Expression and distribution of ectonucleotidases in mouse urinary bladder. PLoS One 6: e18704, 2011.
308. Yu Y, de Groat WC. Effects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat. Brain Res 1361: 43-53, 2010.
309. Zarghooni S, Wunsch J, Bodenbenner M, Bruggmann D, Grando SA, Schwantes U, Wess J, Kummer W, Lips KS. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci 80: 2308-2313, 2007.
310. Zhang CO, Li ZI, Kong CZ. APF, HB-EGF and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. BMC Urol 29: 5-7, 2005.